Interview with Dr. Gary Wu: Studying bacterial metabolites may lead to new treatments for IBD
Dr. Gary D. Wu is a Professor in Gastroenterology at the University of Pennsylvania and currently Director and Chair of the Scientific Advisory Board for the American Gastroenterological Association Center for Gut Microbiome Research and Education.
Dr. Gary D. Wu is a Professor in Gastroenterology at the University of Pennsylvania and currently Director and Chair of the Scientific Advisory Board for the American Gastroenterological Association Center for Gut Microbiome Research and Education. His research examines interactions between gut microbiota and host, particularly focusing on diet and metabolism.
Dr. Wu gave a talk at Experimental Biology 2015 called, “Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease“.
Visit our Gut Microbiota for Health Youtube video channel for more expert interviews!
Also be sure to download our Gut Microbiota & Inflammatory Bowel Disease (IBD) Best of document.
Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014. Find her on: Google • Twitter
While “gut health” is becoming a popular term, mainly in media and marketing claims but also in the clinical context, researchers have not yet nailed down a definition. Now, a global group of 13 scientists and clinicians updates a consensus definition of gut health and implications from bench to bedside.
The management of disorders of gut-brain interaction based on their causes was a central topic addressed at NeuroGASTRO 2025. In this video interview, Dr. Javier Santos delves into the role of mast cells in postprandial symptoms and the present and future of microbiome-based interventions for bowel disorders.
Much of nutrition science has centred on what we put on our plate, yet when we choose to eat may be just as consequential. Intermittent fasting (IF) has gained attention as a strategy that may support metabolic health while also reshaping microbial rhythms, gut hormone secretion, and intestinal function. The growing interest surrounding this approach raises an essential question for clinical practice: does IF truly translate into measurable benefits?
